Edward Rybicki1. 1. a Biopharming Research Unit; Department of Molecular & Cell Biology and Institute of Infectious Disease and Molecular Medicine; University of Cape Town ; Cape Town , South Africa.
Authors: T Kohl; I I Hitzeroth; D Stewart; A Varsani; V A Govan; N D Christensen; A-L Williamson; E P Rybicki Journal: Clin Vaccine Immunol Date: 2006-08
Authors: Wendy A Burgers; Gerald K Chege; Tracey L Müller; Joanne H van Harmelen; Greg Khoury; Enid G Shephard; Clive M Gray; Carolyn Williamson; Anna-Lise Williamson Journal: J Gen Virol Date: 2009-02 Impact factor: 3.891
Authors: Gerald K Chege; Enid G Shephard; Ann Meyers; Joanne van Harmelen; Carolyn Williamson; Alisson Lynch; Clive M Gray; Edward P Rybicki; Anna-Lise Williamson Journal: J Gen Virol Date: 2008-09 Impact factor: 3.891
Authors: Wendy A Burgers; Enid Shephard; James E Monroe; Trish Greenhalgh; Anke Binder; Etienne Hurter; Joanne H Van Harmelen; Carolyn Williamson; Anna-Lise Williamson Journal: AIDS Res Hum Retroviruses Date: 2008-02 Impact factor: 2.205
Authors: J Maclean; M Koekemoer; A J Olivier; D Stewart; I I Hitzeroth; T Rademacher; R Fischer; A-L Williamson; E P Rybicki Journal: J Gen Virol Date: 2007-05 Impact factor: 3.891
Authors: Richard J Halsey; Fiona L Tanzer; Ann Meyers; Sirika Pillay; Alisson Lynch; Enid Shephard; Anna-Lise Williamson; Edward P Rybicki Journal: Virus Res Date: 2008-03-10 Impact factor: 3.303
Authors: Mark Whitehead; Peter Ohlschläger; Fahad N Almajhdi; Leonor Alloza; Pablo Marzábal; Ann E Meyers; Inga I Hitzeroth; Edward P Rybicki Journal: BMC Cancer Date: 2014-05-24 Impact factor: 4.430